FindTrial
Sign In

LIA (Local infiltration analgesia) vs intrathecal morphine for postoperative pain relief after hip arthroplasty

LIA (Local infiltration analgesia) vs intrathecal morphine for postoperative pain relief after hip arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-007470-38-FI
Enrollment
Unknown
Registered
2008-12-12
Start date
2009-01-27
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persons scheduled for hip endoprosthesis operations

Interventions

Trade Name: Morphin,Morfiinihydrokloridi 2 mg/ml respond. morphin. 1,5 mg/ml Leiras Pharmaceutical Form: INN or Proposed INN: MORPHINE CAS Number: 57272 Trade Name: Naropin AstraZeneca Pharmaceuti

Sponsors

Mikko Pitkänen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026